Skip to main content


Page 26 of 29

  1. Authors: Oxana Latycheva, Christine Hampson, Mark Greenwald, Sabrina Panetta and Rupinder Chera
    Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 2):P32

    This article is part of a Supplement: Volume 6 Supplement 2

  2. Osteopontin (OPN) is a multifunctional cytokine that has been primarily investigated in Th1 diseases. Recently, it has also been implicated in Th2-mediated allergic diseases, such as asthma. The expression of ...

    Authors: Serena E O'Neil, Carina Malmhäll, Konstantinos Samitas, Teet Pullerits, Apostolos Bossios and Jan Lötvall
    Citation: Allergy, Asthma & Clinical Immunology 2010 6:28
  3. Little information is available on the effect of allergen-specific immunotherapy on airway responsiveness and markers in exhaled air. The aims of this study were to assess the safety of immunotherapy with puri...

    Authors: Luis Prieto, Ricardo Palacios, Dulce Aldana, Anna Ferrer, Carmen Perez-Frances, Victoria Lopez and Rocio Rojas
    Citation: Allergy, Asthma & Clinical Immunology 2010 6:27
  4. Eosinophilic esophagitis (EoE) is characterized by the inflammation of the esophagus and the infiltration of eosinophils into the esophagus, leading to symptoms such as dysphagia and stricture formation. Syste...

    Authors: Jennifer J Huang, Jae Won Joh, Judy Fuentebella, Anup Patel, Tammie Nguyen, Scott Seki, Lisa Hoyte, Neha Reshamwala, Christine Nguyen, Anthony Quiros, Dorsey Bass, Eric Sibley, William Berquist, Kenneth Cox, John Kerner and Kari C Nadeau
    Citation: Allergy, Asthma & Clinical Immunology 2010 6:25
  5. We published the Canadian 2003 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema (HAE; C1 inhibitor [C1-INH] deficiency) and updated this as Hereditary angio...

    Authors: Tom Bowen, Marco Cicardi, Henriette Farkas, Konrad Bork, Hilary J Longhurst, Bruce Zuraw, Emel Aygoeren-Pürsün, Timothy Craig, Karen Binkley, Jacques Hebert, Bruce Ritchie, Laurence Bouillet, Stephen Betschel, Della Cogar, John Dean, Ramachand Devaraj…
    Citation: Allergy, Asthma & Clinical Immunology 2010 6:24
  6. Advances in understanding the pathophysiology and mechanism of swelling in hereditary angioedema (HAE) has resulted in the development of multiple new drugs for the acute and prophylactic treatment of patients...

    Authors: Bruce L Zuraw
    Citation: Allergy, Asthma & Clinical Immunology 2010 6:23
  7. Hereditary angioedema (C1 inhibitor deficiency, HAE) is associated with intermittent swellings which are disabling and may be fatal. Effective treatments are available and these are most useful when given earl...

    Authors: Hilary J Longhurst, Henriette Farkas, Timothy Craig, Emel Aygören-Pürsün, Claire Bethune, Janne Bjorkander, Konrad Bork, Laurence Bouillet, Henrik Boysen, Anette Bygum, Teresa Caballero, Marco Cicardi, John Dempster, Mark Gompels, Jimmy Gooi, Sofia Grigoriadou…
    Citation: Allergy, Asthma & Clinical Immunology 2010 6:22
  8. Manifestation of acute edema in hereditary angioedema (HAE) is characterized by interindividual and intraindividual variability in symptom expression over time. Flexible therapy options are needed.

    Authors: Emel Aygören-Pürsün, Inmaculada Martinez-Saguer, Eva Rusicke, Thomas Klingebiel and Wolfhart Kreuz
    Citation: Allergy, Asthma & Clinical Immunology 2010 6:21
  9. C1-inhibitor (C1-INH) deficiency is a rare blood disorder resulting in angioedema attacks that are debilitating and may be life-threatening. Prophylaxis and therapy of events has changed since our first Canadi...

    Authors: Tom Bowen, John Brosz, Kristylea Brosz, Jacques Hebert and Bruce Ritchie
    Citation: Allergy, Asthma & Clinical Immunology 2010 6:20
  10. Women with hereditary angioedema (HAE) are more likely to be symptomatic that men. Hormonal factors (puberty, contraception, pregnancy,....) play a significant role in the precipitation or worsening of the con...

    Authors: Laurence Bouillet
    Citation: Allergy, Asthma & Clinical Immunology 2010 6:17
  11. Acquired angioedema (AAE) is characterized by acquired deficiency of C1 inhibitor (C1-INH), hyperactivation of the classical pathway of human complement and angioedema symptoms mediated by bradykinin released ...

    Authors: Marco Cicardi and Andrea Zanichelli
    Citation: Allergy, Asthma & Clinical Immunology 2010 6:14
  12. Primary immune deficiency disorders (PIDs) are a group of diseases associated with a genetic predisposition to recurrent infections, malignancy, autoimmunity and allergy. The molecular basis of many of these d...

    Authors: Rohan Ameratunga, See-Tarn Woon, Katherine Neas and Donald R Love
    Citation: Allergy, Asthma & Clinical Immunology 2010 6:12
  13. The current geriatric population in the United States accounts for approximately 12% of the total population and is projected to reach nearly 20% (71.5 million people) by 2030[1]. With this expansion of the numbe...

    Authors: Jayant M Pinto and Seema Jeswani
    Citation: Allergy, Asthma & Clinical Immunology 2010 6:10
  14. T cell disorders have been poorly understood until recently. Lack of knowledge of underlying molecular mechanisms together with incomplete data on long term outcome have made it difficult to assess prognosis a...

    Authors: Theresa S Cole and Andrew J Cant
    Citation: Allergy, Asthma & Clinical Immunology 2010 6:9

The official journal of CSACI

Annual Journal Metrics

  • 2022 Citation Impact
    2.7 - 2-year Impact Factor
    3.4 - 5-year Impact Factor
    0.989 - SNIP (Source Normalized Impact per Paper)
    0.634 - SJR (SCImago Journal Rank)

    2022 Speed
    16 days submission to first editorial decision for all manuscripts (Median)
    133 days submission to accept (Median)

    2022 Usage 
    5,769 Altmetric mentions